EDITION:
- EU
- NA
In the first of a series of articles taking a deep dive into the market, focusing on everything from its progressive laws surrounding hemp to its supply chains and investment potential, Business of Cannabis will explore the current political climate in the country.
Following a period of relative regulatory stagnation and mounting financial pressure, the global cannabis industry has seen a flurry of
CB21 Pharma, a leading Czech-based pharmaceutical company specializing in producing cannabinoid ingredients and medical devices, has successfully extended its EU
As pharma executives and life science investors navigate through a world of possibilities, the question arises: Is cannabis the high-growth sector that Pharma has been waiting for?
Apollon Formularies Aquis-listed Apollon Formularies has entered into another agreement to sell its ‘global assets’ after announcing that its
Cannabis industry stakeholders from across the world were welcomed to Messe Dortmund this week for the inaugural edition of the
This week, the APPG for Industrial Hemp & CBD met in the Houses of Parliament for a discussion around the
Cantourage This week Cantourage UK, a subsidiary of the German-listed cannabis distribution group, signed a supply agreement which will
Lyphe Group (“Lyphe”), one of the UK’s leading medical cannabis companies, is pleased to announce an innovative partnership set to
CanXChange, the largest B2B cannabis platform in Europe and a leading financial technology company, is proud to announce the launch of its newest service, CX Financing. This innovative product is set to transform the receivables financing landscape, offering exclusive credit terms to our esteemed partners and clients.
We won’t spam you
© 2023 Prohibition Holdings Ltd. All Rights Reserved.
